#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Carotenoids are a group of natural pigments , consisting of more than 750 compounds known so far .
1-1	0-11	Carotenoids	substance	new	coref	3-13[12_0]
1-2	12-15	are	_	_	_	_
1-3	16-17	a	substance[2]	new[2]	_	_
1-4	18-23	group	substance[2]	new[2]	_	_
1-5	24-26	of	substance[2]	new[2]	_	_
1-6	27-34	natural	substance[2]	new[2]	_	_
1-7	35-43	pigments	substance[2]	new[2]	_	_
1-8	44-45	,	_	_	_	_
1-9	46-56	consisting	_	_	_	_
1-10	57-59	of	_	_	_	_
1-11	60-64	more	substance[3]	new[3]	ana	2-1[0_3]
1-12	65-69	than	substance[3]	new[3]	_	_
1-13	70-73	750	substance[3]	new[3]	_	_
1-14	74-83	compounds	substance[3]	new[3]	_	_
1-15	84-89	known	_	_	_	_
1-16	90-92	so	_	_	_	_
1-17	93-96	far	_	_	_	_
1-18	97-98	.	_	_	_	_

#Text=Their colours are mostly yellow , orange , or red due to the system of conjugated double bonds .
2-1	99-104	Their	substance|abstract[5]	giv|new[5]	coref	6-13[30_0]
2-2	105-112	colours	abstract[5]	new[5]	_	_
2-3	113-116	are	_	_	_	_
2-4	117-123	mostly	_	_	_	_
2-5	124-130	yellow	_	_	_	_
2-6	131-132	,	_	_	_	_
2-7	133-139	orange	_	_	_	_
2-8	140-141	,	_	_	_	_
2-9	142-144	or	_	_	_	_
2-10	145-148	red	abstract[6]	new[6]	_	_
2-11	149-152	due	abstract[6]	new[6]	_	_
2-12	153-155	to	_	_	_	_
2-13	156-159	the	abstract[7]	new[7]	_	_
2-14	160-166	system	abstract[7]	new[7]	_	_
2-15	167-169	of	abstract[7]	new[7]	_	_
2-16	170-180	conjugated	abstract[7]|abstract[8]	new[7]|new[8]	_	_
2-17	181-187	double	abstract[7]|abstract[8]	new[7]|new[8]	_	_
2-18	188-193	bonds	abstract[7]|abstract[8]	new[7]|new[8]	_	_
2-19	194-195	.	_	_	_	_

#Text=This structural element is also responsible for the good antioxidant properties of many carotenoids .
3-1	196-200	This	abstract[9]	new[9]	_	_
3-2	201-211	structural	abstract[9]	new[9]	_	_
3-3	212-219	element	abstract[9]	new[9]	_	_
3-4	220-222	is	_	_	_	_
3-5	223-227	also	_	_	_	_
3-6	228-239	responsible	_	_	_	_
3-7	240-243	for	_	_	_	_
3-8	244-247	the	abstract[11]	new[11]	_	_
3-9	248-252	good	abstract[11]	new[11]	_	_
3-10	253-264	antioxidant	person|abstract[11]	new|new[11]	coref	7-63
3-11	265-275	properties	abstract[11]	new[11]	_	_
3-12	276-278	of	abstract[11]	new[11]	_	_
3-13	279-283	many	abstract[11]|substance[12]	new[11]|giv[12]	coref	4-1[0_12]
3-14	284-295	carotenoids	abstract[11]|substance[12]	new[11]|giv[12]	_	_
3-15	296-297	.	_	_	_	_

#Text=Carotenoids have shown numerous biological activities ( not only as provitamin A ) , making them an interesting topic for researchers of various disciplines all over the world looking for , e. g. , preventive properties of fruits and vegetables .
4-1	298-309	Carotenoids	substance	giv	ana	5-5
4-2	310-314	have	_	_	_	_
4-3	315-320	shown	_	_	_	_
4-4	321-329	numerous	abstract[14]	new[14]	ana	4-16[0_14]
4-5	330-340	biological	abstract[14]	new[14]	_	_
4-6	341-351	activities	abstract[14]	new[14]	_	_
4-7	352-353	(	abstract[14]	new[14]	_	_
4-8	354-357	not	abstract[14]	new[14]	_	_
4-9	358-362	only	abstract[14]	new[14]	_	_
4-10	363-365	as	abstract[14]	new[14]	_	_
4-11	366-376	provitamin	abstract[14]	new[14]	_	_
4-12	377-378	A	abstract[14]	new[14]	_	_
4-13	379-380	)	abstract[14]	new[14]	_	_
4-14	381-382	,	_	_	_	_
4-15	383-389	making	_	_	_	_
4-16	390-394	them	abstract	giv	coref	9-38[66_0]
4-17	395-397	an	_	_	_	_
4-18	398-409	interesting	_	_	_	_
4-19	410-415	topic	_	_	_	_
4-20	416-419	for	_	_	_	_
4-21	420-431	researchers	person[16]	new[16]	_	_
4-22	432-434	of	person[16]	new[16]	_	_
4-23	435-442	various	person[16]|abstract[17]	new[16]|new[17]	_	_
4-24	443-454	disciplines	person[16]|abstract[17]	new[16]|new[17]	_	_
4-25	455-458	all	person[16]|abstract[17]|place[18]	new[16]|new[17]|new[18]	_	_
4-26	459-463	over	person[16]|abstract[17]|place[18]	new[16]|new[17]|new[18]	_	_
4-27	464-467	the	person[16]|abstract[17]|place[18]	new[16]|new[17]|new[18]	_	_
4-28	468-473	world	person[16]|abstract[17]|place[18]	new[16]|new[17]|new[18]	_	_
4-29	474-481	looking	_	_	_	_
4-30	482-485	for	_	_	_	_
4-31	486-487	,	_	_	_	_
4-32	488-490	e.	_	_	_	_
4-33	491-493	g.	_	_	_	_
4-34	494-495	,	_	_	_	_
4-35	496-506	preventive	abstract[19]	new[19]	coref	20-10[136_19]
4-36	507-517	properties	abstract[19]	new[19]	_	_
4-37	518-520	of	abstract[19]	new[19]	_	_
4-38	521-527	fruits	abstract[19]|plant	new[19]|new	_	_
4-39	528-531	and	abstract[19]	new[19]	_	_
4-40	532-542	vegetables	abstract[19]|plant	new[19]|new	_	_
4-41	543-544	.	_	_	_	_

#Text=As lipophilic compounds , their uptake and storage in the body are dependent on various conditions .
5-1	545-547	As	_	_	_	_
5-2	548-558	lipophilic	_	_	_	_
5-3	559-568	compounds	_	_	_	_
5-4	569-570	,	_	_	_	_
5-5	571-576	their	substance|abstract[23]	giv|new[23]	coref	6-20
5-6	577-583	uptake	abstract[23]	new[23]	_	_
5-7	584-587	and	_	_	_	_
5-8	588-595	storage	place[24]	new[24]	_	_
5-9	596-598	in	place[24]	new[24]	_	_
5-10	599-602	the	place[24]|place[25]	new[24]|new[25]	_	_
5-11	603-607	body	place[24]|place[25]	new[24]|new[25]	_	_
5-12	608-611	are	_	_	_	_
5-13	612-621	dependent	_	_	_	_
5-14	622-624	on	_	_	_	_
5-15	625-632	various	abstract[26]	new[26]	_	_
5-16	633-643	conditions	abstract[26]	new[26]	_	_
5-17	644-645	.	_	_	_	_

#Text=In vitro and in vivo data showed stimulating and inhibitory effects of matrix compounds on bioaccessibility and bioavailability of carotenoids .
6-1	646-648	In	_	_	_	_
6-2	649-654	vitro	_	_	_	_
6-3	655-658	and	_	_	_	_
6-4	659-661	in	_	_	_	_
6-5	662-666	vivo	abstract[27]	new[27]	_	_
6-6	667-671	data	abstract[27]	new[27]	_	_
6-7	672-678	showed	_	_	_	_
6-8	679-690	stimulating	abstract[28]	new[28]	_	_
6-9	691-694	and	abstract[28]	new[28]	_	_
6-10	695-705	inhibitory	abstract[28]	new[28]	_	_
6-11	706-713	effects	abstract[28]	new[28]	_	_
6-12	714-716	of	abstract[28]	new[28]	_	_
6-13	717-723	matrix	abstract[28]|abstract|substance[30]	new[28]|new|giv[30]	_	_
6-14	724-733	compounds	abstract[28]|substance[30]	new[28]|giv[30]	_	_
6-15	734-736	on	abstract[28]|substance[30]	new[28]|giv[30]	_	_
6-16	737-753	bioaccessibility	abstract[28]|substance[30]|abstract|abstract[32]	new[28]|giv[30]|new|new[32]	ana	7-5[36_32]
6-17	754-757	and	abstract[28]|substance[30]|abstract[32]	new[28]|giv[30]|new[32]	_	_
6-18	758-773	bioavailability	abstract[28]|substance[30]|abstract[32]|substance[33]	new[28]|giv[30]|new[32]|new[33]	_	_
6-19	774-776	of	abstract[28]|substance[30]|abstract[32]|substance[33]	new[28]|giv[30]|new[32]|new[33]	_	_
6-20	777-788	carotenoids	abstract[28]|substance[30]|abstract[32]|substance[33]|substance	new[28]|giv[30]|new[32]|new[33]|giv	coref	11-6
6-21	789-790	.	_	_	_	_

#Text=This special issue highlights some of the recent advances in carotenoid research , showing on the one hand the status quo and giving on the other hand new insight in functions and physiological relevance . Al-Yafeai et al. investigated rosehips of Rosa rugosa at different degrees of ripeness and showed that maturity stage significantly affected contents of bioactive ingredients as well as antioxidant capacity .
7-1	791-795	This	abstract[35]	new[35]	coref	26-3[177_35]
7-2	796-803	special	abstract[35]	new[35]	_	_
7-3	804-809	issue	abstract[35]	new[35]	_	_
7-4	810-820	highlights	_	_	_	_
7-5	821-825	some	abstract[36]	giv[36]	_	_
7-6	826-828	of	abstract[36]	giv[36]	_	_
7-7	829-832	the	abstract[36]|abstract[37]	giv[36]|new[37]	_	_
7-8	833-839	recent	abstract[36]|abstract[37]	giv[36]|new[37]	_	_
7-9	840-848	advances	abstract[36]|abstract[37]	giv[36]|new[37]	_	_
7-10	849-851	in	abstract[36]|abstract[37]	giv[36]|new[37]	_	_
7-11	852-862	carotenoid	abstract[36]|abstract[37]|abstract[38]	giv[36]|new[37]|new[38]	_	_
7-12	863-871	research	abstract[36]|abstract[37]|abstract[38]	giv[36]|new[37]|new[38]	_	_
7-13	872-873	,	_	_	_	_
7-14	874-881	showing	_	_	_	_
7-15	882-884	on	_	_	_	_
7-16	885-888	the	_	_	_	_
7-17	889-892	one	_	_	_	_
7-18	893-897	hand	_	_	_	_
7-19	898-901	the	abstract[39]	new[39]	_	_
7-20	902-908	status	abstract[39]	new[39]	_	_
7-21	909-912	quo	abstract[39]	new[39]	_	_
7-22	913-916	and	_	_	_	_
7-23	917-923	giving	_	_	_	_
7-24	924-926	on	_	_	_	_
7-25	927-930	the	abstract[40]	new[40]	_	_
7-26	931-936	other	abstract[40]	new[40]	_	_
7-27	937-941	hand	abstract[40]	new[40]	_	_
7-28	942-945	new	abstract[40]	new[40]	_	_
7-29	946-953	insight	abstract[40]	new[40]	_	_
7-30	954-956	in	abstract[40]	new[40]	_	_
7-31	957-966	functions	abstract[40]|abstract	new[40]|new	_	_
7-32	967-970	and	abstract[40]	new[40]	_	_
7-33	971-984	physiological	abstract[40]|abstract[42]	new[40]|new[42]	_	_
7-34	985-994	relevance	abstract[40]|abstract[42]	new[40]|new[42]	_	_
7-35	995-996	.	abstract[40]	new[40]	_	_
7-36	997-1006	Al-Yafeai	abstract[40]|person	new[40]|new	_	_
7-37	1007-1009	et	abstract[40]	new[40]	_	_
7-38	1010-1013	al.	abstract[40]	new[40]	_	_
7-39	1014-1026	investigated	abstract[40]	new[40]	_	_
7-40	1027-1035	rosehips	abstract[40]|plant[44]	new[40]|new[44]	_	_
7-41	1036-1038	of	abstract[40]|plant[44]	new[40]|new[44]	_	_
7-42	1039-1043	Rosa	abstract[40]|plant[44]|person	new[40]|new[44]|new	_	_
7-43	1044-1050	rugosa	abstract[40]|plant[44]	new[40]|new[44]	_	_
7-44	1051-1053	at	abstract[40]|plant[44]	new[40]|new[44]	_	_
7-45	1054-1063	different	abstract[40]|plant[44]|abstract[46]	new[40]|new[44]|new[46]	_	_
7-46	1064-1071	degrees	abstract[40]|plant[44]|abstract[46]	new[40]|new[44]|new[46]	_	_
7-47	1072-1074	of	abstract[40]|plant[44]|abstract[46]	new[40]|new[44]|new[46]	_	_
7-48	1075-1083	ripeness	abstract[40]|plant[44]|abstract[46]|abstract	new[40]|new[44]|new[46]|new	_	_
7-49	1084-1087	and	_	_	_	_
7-50	1088-1094	showed	_	_	_	_
7-51	1095-1099	that	_	_	_	_
7-52	1100-1108	maturity	event|abstract[49]	new|new[49]	coref	24-5[160_49]
7-53	1109-1114	stage	abstract[49]	new[49]	_	_
7-54	1115-1128	significantly	object[50]	new[50]	_	_
7-55	1129-1137	affected	object[50]	new[50]	_	_
7-56	1138-1146	contents	object[50]	new[50]	_	_
7-57	1147-1149	of	object[50]	new[50]	_	_
7-58	1150-1159	bioactive	object[50]|substance[51]	new[50]|new[51]	_	_
7-59	1160-1171	ingredients	object[50]|substance[51]	new[50]|new[51]	_	_
7-60	1172-1174	as	_	_	_	_
7-61	1175-1179	well	_	_	_	_
7-62	1180-1182	as	_	_	_	_
7-63	1183-1194	antioxidant	person|abstract[53]	giv|new[53]	coref	14-6
7-64	1195-1203	capacity	abstract[53]	new[53]	_	_
7-65	1204-1205	.	_	_	_	_

#Text=Thus , harvesting date can be chosen depending on the contents of bioactive molecules .
8-1	1206-1210	Thus	_	_	_	_
8-2	1211-1212	,	_	_	_	_
8-3	1213-1223	harvesting	_	_	_	_
8-4	1224-1228	date	time	new	_	_
8-5	1229-1232	can	_	_	_	_
8-6	1233-1235	be	_	_	_	_
8-7	1236-1242	chosen	_	_	_	_
8-8	1243-1252	depending	_	_	_	_
8-9	1253-1255	on	_	_	_	_
8-10	1256-1259	the	object[55]	new[55]	coref	24-15[162_55]
8-11	1260-1268	contents	object[55]	new[55]	_	_
8-12	1269-1271	of	object[55]	new[55]	_	_
8-13	1272-1281	bioactive	object[55]|substance[56]	new[55]|new[56]	coref	12-1[82_56]
8-14	1282-1291	molecules	object[55]|substance[56]	new[55]|new[56]	_	_
8-15	1292-1293	.	_	_	_	_

#Text=In addition , the authors fully characterized ( 5’Z ) -rubixanthin ( gazaniaxanthin ) as the main ( Z )-isomer of rubixanthin in hips of R. rugosa by using HPLC-MS/MS and NMR . Chitong et al. investigated biological activities of astaxanthin extracted from shrimp waste .
9-1	1294-1296	In	_	_	_	_
9-2	1297-1305	addition	_	_	_	_
9-3	1306-1307	,	_	_	_	_
9-4	1308-1311	the	person[57]	new[57]	ana	10-1[0_57]
9-5	1312-1319	authors	person[57]	new[57]	_	_
9-6	1320-1325	fully	_	_	_	_
9-7	1326-1339	characterized	_	_	_	_
9-8	1340-1341	(	_	_	_	_
9-9	1342-1345	5’Z	abstract	new	_	_
9-10	1346-1347	)	_	_	_	_
9-11	1348-1360	-rubixanthin	_	_	_	_
9-12	1361-1362	(	_	_	_	_
9-13	1363-1377	gazaniaxanthin	substance	new	_	_
9-14	1378-1379	)	_	_	_	_
9-15	1380-1382	as	_	_	_	_
9-16	1383-1386	the	_	_	_	_
9-17	1387-1391	main	_	_	_	_
9-18	1392-1393	(	_	_	_	_
9-19	1394-1395	Z	person	new	_	_
9-20	1396-1404	)-isomer	_	_	_	_
9-21	1405-1407	of	_	_	_	_
9-22	1408-1419	rubixanthin	substance	new	_	_
9-23	1420-1422	in	_	_	_	_
9-24	1423-1427	hips	animal[62]	new[62]	_	_
9-25	1428-1430	of	animal[62]	new[62]	_	_
9-26	1431-1433	R.	animal[62]	new[62]	_	_
9-27	1434-1440	rugosa	animal[62]	new[62]	_	_
9-28	1441-1443	by	_	_	_	_
9-29	1444-1449	using	_	_	_	_
9-30	1450-1460	HPLC-MS/MS	abstract	new	_	_
9-31	1461-1464	and	_	_	_	_
9-32	1465-1468	NMR	abstract	new	_	_
9-33	1469-1470	.	_	_	_	_
9-34	1471-1478	Chitong	person	new	_	_
9-35	1479-1481	et	_	_	_	_
9-36	1482-1485	al.	_	_	_	_
9-37	1486-1498	investigated	_	_	_	_
9-38	1499-1509	biological	abstract[66]	giv[66]	_	_
9-39	1510-1520	activities	abstract[66]	giv[66]	_	_
9-40	1521-1523	of	abstract[66]	giv[66]	_	_
9-41	1524-1535	astaxanthin	abstract[66]|substance	giv[66]|new	_	_
9-42	1536-1545	extracted	_	_	_	_
9-43	1546-1550	from	_	_	_	_
9-44	1551-1557	shrimp	animal|substance[69]	new|new[69]	_	_
9-45	1558-1563	waste	substance[69]	new[69]	_	_
9-46	1564-1565	.	_	_	_	_

#Text=They discussed a possible use of this extract in dietary supplements for skin health applications .
10-1	1566-1570	They	person	giv	coref	17-1[112_0]
10-2	1571-1580	discussed	_	_	_	_
10-3	1581-1582	a	abstract[71]	new[71]	_	_
10-4	1583-1591	possible	abstract[71]	new[71]	_	_
10-5	1592-1595	use	abstract[71]	new[71]	_	_
10-6	1596-1598	of	abstract[71]	new[71]	_	_
10-7	1599-1603	this	abstract[71]|substance[72]	new[71]|new[72]	_	_
10-8	1604-1611	extract	abstract[71]|substance[72]	new[71]|new[72]	_	_
10-9	1612-1614	in	abstract[71]|substance[72]	new[71]|new[72]	_	_
10-10	1615-1622	dietary	abstract[71]|substance[72]|abstract|object[74]	new[71]|new[72]|new|new[74]	_	_
10-11	1623-1634	supplements	abstract[71]|substance[72]|object[74]	new[71]|new[72]|new[74]	_	_
10-12	1635-1638	for	abstract[71]|substance[72]|object[74]	new[71]|new[72]|new[74]	_	_
10-13	1639-1643	skin	abstract[71]|substance[72]|object[74]|object|abstract[77]	new[71]|new[72]|new[74]|new|new[77]	coref	21-31
10-14	1644-1650	health	abstract[71]|substance[72]|object[74]|abstract|abstract[77]	new[71]|new[72]|new[74]|new|new[77]	coref	16-20[111_0]
10-15	1651-1663	applications	abstract[71]|substance[72]|object[74]|abstract[77]	new[71]|new[72]|new[74]|new[77]	_	_
10-16	1664-1665	.	_	_	_	_

#Text=Apocarotenoids are cleavage products of carotenoids .
11-1	1666-1680	Apocarotenoids	object	new	coref	11-3[80_0]
11-2	1681-1684	are	_	_	_	_
11-3	1685-1693	cleavage	person|object[80]	new|giv[80]	_	_
11-4	1694-1702	products	object[80]	giv[80]	_	_
11-5	1703-1705	of	object[80]	giv[80]	_	_
11-6	1706-1717	carotenoids	object[80]|substance	giv[80]|giv	coref	14-14
11-7	1718-1719	.	_	_	_	_

#Text=These molecules often showed biological activity .
12-1	1720-1725	These	substance[82]	giv[82]	_	_
12-2	1726-1735	molecules	substance[82]	giv[82]	_	_
12-3	1736-1741	often	_	_	_	_
12-4	1742-1748	showed	_	_	_	_
12-5	1749-1759	biological	abstract[83]	new[83]	coref	21-10[141_83]
12-6	1760-1768	activity	abstract[83]	new[83]	_	_
12-7	1769-1770	.	_	_	_	_

#Text=Thus , Zoccali et al. extracted four microalgae strains and characterized the apocarotenoids therein .
13-1	1771-1775	Thus	_	_	_	_
13-2	1776-1777	,	_	_	_	_
13-3	1778-1785	Zoccali	person	new	_	_
13-4	1786-1788	et	_	_	_	_
13-5	1789-1792	al.	_	_	_	_
13-6	1793-1802	extracted	_	_	_	_
13-7	1803-1807	four	object[86]	new[86]	_	_
13-8	1808-1818	microalgae	animal|object[86]	new|new[86]	_	_
13-9	1819-1826	strains	object[86]	new[86]	_	_
13-10	1827-1830	and	_	_	_	_
13-11	1831-1844	characterized	_	_	_	_
13-12	1845-1848	the	abstract[87]	new[87]	_	_
13-13	1849-1863	apocarotenoids	abstract[87]	new[87]	_	_
13-14	1864-1871	therein	_	_	_	_
13-15	1872-1873	.	_	_	_	_

#Text=Sandmann reviews structure dependence of antioxidant protection from UV and light stress by carotenoids .
14-1	1874-1882	Sandmann	person	new	_	_
14-2	1883-1890	reviews	abstract	new	coref|none	16-1[104_0]|14-2[0_104]
14-3	1891-1900	structure	abstract|abstract[90]	new|new[90]	_	_
14-4	1901-1911	dependence	abstract[90]	new[90]	_	_
14-5	1912-1914	of	abstract[90]	new[90]	_	_
14-6	1915-1926	antioxidant	abstract[90]|person|abstract[92]	new[90]|giv|new[92]	coref	20-11
14-7	1927-1937	protection	abstract[90]|abstract[92]	new[90]|new[92]	_	_
14-8	1938-1942	from	abstract[90]|abstract[92]	new[90]|new[92]	_	_
14-9	1943-1945	UV	abstract[90]|abstract[92]|substance	new[90]|new[92]|new	_	_
14-10	1946-1949	and	abstract[90]|abstract[92]	new[90]|new[92]	_	_
14-11	1950-1955	light	abstract[90]|abstract[92]|abstract|abstract[95]	new[90]|new[92]|new|new[95]	_	_
14-12	1956-1962	stress	abstract[90]|abstract[92]|abstract[95]	new[90]|new[92]|new[95]	_	_
14-13	1963-1965	by	_	_	_	_
14-14	1966-1977	carotenoids	substance	giv	coref	16-15[108_0]
14-15	1978-1979	.	_	_	_	_

#Text=Substitutions at the hydrocarbon molecule are important for good singlet oxygen quenching and radical scavenging .
15-1	1980-1993	Substitutions	abstract[97]	new[97]	_	_
15-2	1994-1996	at	abstract[97]	new[97]	_	_
15-3	1997-2000	the	abstract[97]|substance[99]	new[97]|new[99]	_	_
15-4	2001-2012	hydrocarbon	abstract[97]|substance|substance[99]	new[97]|new|new[99]	_	_
15-5	2013-2021	molecule	abstract[97]|substance[99]	new[97]|new[99]	_	_
15-6	2022-2025	are	_	_	_	_
15-7	2026-2035	important	_	_	_	_
15-8	2036-2039	for	_	_	_	_
15-9	2040-2044	good	substance[102]	new[102]	_	_
15-10	2045-2052	singlet	object|substance[102]	new|new[102]	_	_
15-11	2053-2059	oxygen	substance|substance[102]	new|new[102]	_	_
15-12	2060-2069	quenching	substance[102]	new[102]	_	_
15-13	2070-2073	and	_	_	_	_
15-14	2074-2081	radical	abstract[103]	new[103]	_	_
15-15	2082-2092	scavenging	abstract[103]	new[103]	_	_
15-16	2093-2094	.	_	_	_	_

#Text=The review by Elvira-Torales et al. gives an overview on beneficial health-related effects of carotenoids with special emphasis on liver health .
16-1	2095-2098	The	abstract[104]	new[104]	_	_
16-2	2099-2105	review	abstract[104]	new[104]	_	_
16-3	2106-2108	by	abstract[104]	new[104]	_	_
16-4	2109-2123	Elvira-Torales	abstract[104]|person	new[104]|new	_	_
16-5	2124-2126	et	abstract[104]	new[104]	_	_
16-6	2127-2130	al.	abstract[104]	new[104]	_	_
16-7	2131-2136	gives	_	_	_	_
16-8	2137-2139	an	abstract[106]	new[106]	_	_
16-9	2140-2148	overview	abstract[106]	new[106]	_	_
16-10	2149-2151	on	abstract[106]	new[106]	_	_
16-11	2152-2162	beneficial	abstract[106]|abstract[107]	new[106]|new[107]	_	_
16-12	2163-2177	health-related	abstract[106]|abstract[107]	new[106]|new[107]	_	_
16-13	2178-2185	effects	abstract[106]|abstract[107]	new[106]|new[107]	_	_
16-14	2186-2188	of	abstract[106]|abstract[107]	new[106]|new[107]	_	_
16-15	2189-2200	carotenoids	abstract[106]|abstract[107]|substance[108]	new[106]|new[107]|giv[108]	coref	17-9[0_108]
16-16	2201-2205	with	abstract[106]|abstract[107]|substance[108]	new[106]|new[107]|giv[108]	_	_
16-17	2206-2213	special	abstract[106]|abstract[107]|substance[108]|abstract[109]	new[106]|new[107]|giv[108]|new[109]	_	_
16-18	2214-2222	emphasis	abstract[106]|abstract[107]|substance[108]|abstract[109]	new[106]|new[107]|giv[108]|new[109]	_	_
16-19	2223-2225	on	abstract[106]|abstract[107]|substance[108]|abstract[109]	new[106]|new[107]|giv[108]|new[109]	_	_
16-20	2226-2231	liver	abstract[106]|abstract[107]|substance[108]|abstract[109]|object|abstract[111]	new[106]|new[107]|giv[108]|new[109]|new|giv[111]	coref	17-17
16-21	2232-2238	health	abstract[106]|abstract[107]|substance[108]|abstract[109]|abstract[111]	new[106]|new[107]|giv[108]|new[109]|giv[111]	_	_
16-22	2239-2240	.	_	_	_	_

#Text=The authors described , e. g. , how carotenoids can interact in patients with non-alcoholic fatty liver disease ( NAFLD ) .
17-1	2241-2244	The	person[112]	giv[112]	coref	19-1[124_112]
17-2	2245-2252	authors	person[112]	giv[112]	_	_
17-3	2253-2262	described	_	_	_	_
17-4	2263-2264	,	_	_	_	_
17-5	2265-2267	e.	event[113]	new[113]	_	_
17-6	2268-2270	g.	event[113]	new[113]	_	_
17-7	2271-2272	,	_	_	_	_
17-8	2273-2276	how	_	_	_	_
17-9	2277-2288	carotenoids	substance	giv	coref	21-29[148_0]
17-10	2289-2292	can	_	_	_	_
17-11	2293-2301	interact	_	_	_	_
17-12	2302-2304	in	_	_	_	_
17-13	2305-2313	patients	person[115]	new[115]	_	_
17-14	2314-2318	with	person[115]	new[115]	_	_
17-15	2319-2332	non-alcoholic	person[115]|abstract[117]	new[115]|new[117]	appos	17-20[0_117]
17-16	2333-2338	fatty	person[115]|abstract[117]	new[115]|new[117]	_	_
17-17	2339-2344	liver	person[115]|object|abstract[117]	new[115]|giv|new[117]	coref	19-5
17-18	2345-2352	disease	person[115]|abstract[117]	new[115]|new[117]	_	_
17-19	2353-2354	(	_	_	_	_
17-20	2355-2360	NAFLD	abstract	giv	coref	19-17[131_0]
17-21	2361-2362	)	_	_	_	_
17-22	2363-2364	.	_	_	_	_

#Text=Results of an experiment using Wistar rats are presented by Róvera Costa et al.
18-1	2365-2372	Results	object[119]	new[119]	_	_
18-2	2373-2375	of	object[119]	new[119]	_	_
18-3	2376-2378	an	object[119]|event[120]	new[119]|new[120]	_	_
18-4	2379-2389	experiment	object[119]|event[120]	new[119]|new[120]	_	_
18-5	2390-2395	using	_	_	_	_
18-6	2396-2402	Wistar	person|animal[122]	new|new[122]	_	_
18-7	2403-2407	rats	animal[122]	new[122]	_	_
18-8	2408-2411	are	_	_	_	_
18-9	2412-2421	presented	_	_	_	_
18-10	2422-2424	by	_	_	_	_
18-11	2425-2431	Róvera	person[123]	new[123]	_	_
18-12	2432-2437	Costa	person[123]	new[123]	_	_
18-13	2438-2440	et	person[123]	new[123]	_	_
18-14	2441-2444	al.	person[123]	new[123]	_	_

#Text=The authors evaluated the liver protective effects of supplementation ( 10 weeks ) with lycopene on non-alcoholic fatty liver disease .
19-1	2445-2448	The	person[124]	giv[124]	coref	24-1[158_124]
19-2	2449-2456	authors	person[124]	giv[124]	_	_
19-3	2457-2466	evaluated	_	_	_	_
19-4	2467-2470	the	abstract[126]	new[126]	_	_
19-5	2471-2476	liver	object|abstract[126]	giv|new[126]	coref	19-19
19-6	2477-2487	protective	abstract[126]	new[126]	_	_
19-7	2488-2495	effects	abstract[126]	new[126]	_	_
19-8	2496-2498	of	abstract[126]	new[126]	_	_
19-9	2499-2514	supplementation	abstract[126]|substance	new[126]|new	_	_
19-10	2515-2516	(	_	_	_	_
19-11	2517-2519	10	time[128]	new[128]	_	_
19-12	2520-2525	weeks	time[128]	new[128]	_	_
19-13	2526-2527	)	_	_	_	_
19-14	2528-2532	with	_	_	_	_
19-15	2533-2541	lycopene	substance[129]	new[129]	coref	24-28[167_129]
19-16	2542-2544	on	substance[129]	new[129]	_	_
19-17	2545-2558	non-alcoholic	substance[129]|abstract[131]	new[129]|giv[131]	_	_
19-18	2559-2564	fatty	substance[129]|abstract[131]	new[129]|giv[131]	_	_
19-19	2565-2570	liver	substance[129]|object|abstract[131]	new[129]|giv|giv[131]	_	_
19-20	2571-2578	disease	substance[129]|abstract[131]	new[129]|giv[131]	_	_
19-21	2579-2580	.	_	_	_	_

#Text=Chambers et al. synthesized special retinoyl-flavonolignan hybrids and investigated their antioxidant properties .
20-1	2581-2589	Chambers	person	new	ana	20-10
20-2	2590-2592	et	_	_	_	_
20-3	2593-2596	al.	_	_	_	_
20-4	2597-2608	synthesized	_	_	_	_
20-5	2609-2616	special	object[133]	new[133]	_	_
20-6	2617-2639	retinoyl-flavonolignan	object[133]	new[133]	_	_
20-7	2640-2647	hybrids	object[133]	new[133]	_	_
20-8	2648-2651	and	_	_	_	_
20-9	2652-2664	investigated	_	_	_	_
20-10	2665-2670	their	person|abstract[136]	giv|giv[136]	_	_
20-11	2671-2682	antioxidant	person|abstract[136]	giv|giv[136]	coref	24-40
20-12	2683-2693	properties	abstract[136]	giv[136]	_	_
20-13	2694-2695	.	_	_	_	_

#Text=The paper of Karpiński and Adamczak reports results of antimicrobial activity of the carotenoid fucoxanthin against 20 bacterial species . Balić et al. review the photoprotective properties of carotenoids in skin .
21-1	2696-2699	The	abstract[137]	new[137]	_	_
21-2	2700-2705	paper	abstract[137]	new[137]	_	_
21-3	2706-2708	of	abstract[137]	new[137]	_	_
21-4	2709-2718	Karpiński	abstract[137]|person	new[137]|new	_	_
21-5	2719-2722	and	abstract[137]	new[137]	_	_
21-6	2723-2731	Adamczak	abstract[137]|person	new[137]|new	_	_
21-7	2732-2739	reports	_	_	_	_
21-8	2740-2747	results	abstract[140]	new[140]	coref	26-7[178_140]
21-9	2748-2750	of	abstract[140]	new[140]	_	_
21-10	2751-2764	antimicrobial	abstract[140]|abstract[141]	new[140]|giv[141]	coref	24-40[172_141]
21-11	2765-2773	activity	abstract[140]|abstract[141]	new[140]|giv[141]	_	_
21-12	2774-2776	of	abstract[140]|abstract[141]	new[140]|giv[141]	_	_
21-13	2777-2780	the	abstract[140]|abstract[141]|substance[143]	new[140]|giv[141]|new[143]	_	_
21-14	2781-2791	carotenoid	abstract[140]|abstract[141]|object|substance[143]	new[140]|giv[141]|new|new[143]	_	_
21-15	2792-2803	fucoxanthin	abstract[140]|abstract[141]|substance[143]	new[140]|giv[141]|new[143]	_	_
21-16	2804-2811	against	abstract[140]|abstract[141]	new[140]|giv[141]	_	_
21-17	2812-2814	20	abstract[140]|abstract[141]|animal[145]	new[140]|giv[141]|new[145]	_	_
21-18	2815-2824	bacterial	abstract[140]|abstract[141]|animal|animal[145]	new[140]|giv[141]|new|new[145]	_	_
21-19	2825-2832	species	abstract[140]|abstract[141]|animal[145]	new[140]|giv[141]|new[145]	_	_
21-20	2833-2834	.	_	_	_	_
21-21	2835-2840	Balić	person	new	_	_
21-22	2841-2843	et	_	_	_	_
21-23	2844-2847	al.	_	_	_	_
21-24	2848-2854	review	_	_	_	_
21-25	2855-2858	the	abstract[147]	new[147]	_	_
21-26	2859-2874	photoprotective	abstract[147]	new[147]	_	_
21-27	2875-2885	properties	abstract[147]	new[147]	_	_
21-28	2886-2888	of	abstract[147]	new[147]	_	_
21-29	2889-2900	carotenoids	abstract[147]|substance[148]	new[147]|giv[148]	coref	22-1[151_148]
21-30	2901-2903	in	abstract[147]|substance[148]	new[147]|giv[148]	_	_
21-31	2904-2908	skin	abstract[147]|substance[148]|object	new[147]|giv[148]|giv	_	_
21-32	2909-2910	.	_	_	_	_

#Text=Dietary carotenoids accumulate in the epidermis and act as a protective barrier to various environmental influences .
22-1	2911-2918	Dietary	person|substance[151]	new|giv[151]	coref	26-17[181_151]
22-2	2919-2930	carotenoids	substance[151]	giv[151]	_	_
22-3	2931-2941	accumulate	_	_	_	_
22-4	2942-2944	in	_	_	_	_
22-5	2945-2948	the	place[152]	new[152]	_	_
22-6	2949-2958	epidermis	place[152]	new[152]	_	_
22-7	2959-2962	and	_	_	_	_
22-8	2963-2966	act	_	_	_	_
22-9	2967-2969	as	_	_	_	_
22-10	2970-2971	a	_	_	_	_
22-11	2972-2982	protective	_	_	_	_
22-12	2983-2990	barrier	_	_	_	_
22-13	2991-2993	to	_	_	_	_
22-14	2994-3001	various	abstract[153]	new[153]	_	_
22-15	3002-3015	environmental	abstract[153]	new[153]	_	_
22-16	3016-3026	influences	abstract[153]	new[153]	_	_
22-17	3027-3028	.	_	_	_	_

#Text=In vitro digestion experiments with human milk were done by Xavier et al.
23-1	3029-3031	In	_	_	_	_
23-2	3032-3037	vitro	event[155]	new[155]	_	_
23-3	3038-3047	digestion	abstract|event[155]	new|new[155]	_	_
23-4	3048-3059	experiments	event[155]	new[155]	_	_
23-5	3060-3064	with	event[155]	new[155]	_	_
23-6	3065-3070	human	event[155]|substance[156]	new[155]|new[156]	_	_
23-7	3071-3075	milk	event[155]|substance[156]	new[155]|new[156]	_	_
23-8	3076-3080	were	_	_	_	_
23-9	3081-3085	done	_	_	_	_
23-10	3086-3088	by	_	_	_	_
23-11	3089-3095	Xavier	person	new	_	_
23-12	3096-3098	et	_	_	_	_
23-13	3099-3102	al.	_	_	_	_

#Text=These authors investigated how the lactation stage ( colostrum , mature milk ) affected the carotenoid contents in micelles . Wang et al. prepared inclusion complexes of lycopene in β-cyclodextrin and characterized these complexes by looking for stability and antioxidant activity .
24-1	3103-3108	These	person[158]	giv[158]	_	_
24-2	3109-3116	authors	person[158]	giv[158]	_	_
24-3	3117-3129	investigated	_	_	_	_
24-4	3130-3133	how	_	_	_	_
24-5	3134-3137	the	abstract[160]	giv[160]	appos	24-9[0_160]
24-6	3138-3147	lactation	object|abstract[160]	new|giv[160]	_	_
24-7	3148-3153	stage	abstract[160]	giv[160]	_	_
24-8	3154-3155	(	_	_	_	_
24-9	3156-3165	colostrum	abstract	giv	_	_
24-10	3166-3167	,	_	_	_	_
24-11	3168-3174	mature	_	_	_	_
24-12	3175-3179	milk	_	_	_	_
24-13	3180-3181	)	_	_	_	_
24-14	3182-3190	affected	_	_	_	_
24-15	3191-3194	the	object[162]	giv[162]	_	_
24-16	3195-3205	carotenoid	object[162]	giv[162]	_	_
24-17	3206-3214	contents	object[162]	giv[162]	_	_
24-18	3215-3217	in	object[162]	giv[162]	_	_
24-19	3218-3226	micelles	object[162]|animal	giv[162]|new	_	_
24-20	3227-3228	.	_	_	_	_
24-21	3229-3233	Wang	person	new	_	_
24-22	3234-3236	et	_	_	_	_
24-23	3237-3240	al.	_	_	_	_
24-24	3241-3249	prepared	_	_	_	_
24-25	3250-3259	inclusion	person|object[166]	new|new[166]	coref	24-33[169_166]
24-26	3260-3269	complexes	object[166]	new[166]	_	_
24-27	3270-3272	of	object[166]	new[166]	_	_
24-28	3273-3281	lycopene	object[166]|substance[167]	new[166]|giv[167]	coref	25-1[0_167]
24-29	3282-3284	in	object[166]|substance[167]	new[166]|giv[167]	_	_
24-30	3285-3299	β-cyclodextrin	object[166]|substance[167]|substance	new[166]|giv[167]|new	coref	25-8
24-31	3300-3303	and	_	_	_	_
24-32	3304-3317	characterized	_	_	_	_
24-33	3318-3323	these	object[169]	giv[169]	_	_
24-34	3324-3333	complexes	object[169]	giv[169]	_	_
24-35	3334-3336	by	_	_	_	_
24-36	3337-3344	looking	_	_	_	_
24-37	3345-3348	for	_	_	_	_
24-38	3349-3358	stability	abstract	new	_	_
24-39	3359-3362	and	_	_	_	_
24-40	3363-3374	antioxidant	person|abstract[172]	giv|giv[172]	_	_
24-41	3375-3383	activity	abstract[172]	giv[172]	_	_
24-42	3384-3385	.	_	_	_	_

#Text=Lycopene was embedded into the cavity of β-cyclodextrin with a 1:1 stoichiometry .
25-1	3386-3394	Lycopene	substance	giv	_	_
25-2	3395-3398	was	_	_	_	_
25-3	3399-3407	embedded	_	_	_	_
25-4	3408-3412	into	_	_	_	_
25-5	3413-3416	the	object[174]	new[174]	_	_
25-6	3417-3423	cavity	object[174]	new[174]	_	_
25-7	3424-3426	of	object[174]	new[174]	_	_
25-8	3427-3441	β-cyclodextrin	object[174]|substance	new[174]|giv	_	_
25-9	3442-3446	with	_	_	_	_
25-10	3447-3448	a	quantity[176]	new[176]	_	_
25-11	3449-3452	1:1	quantity[176]	new[176]	_	_
25-12	3453-3466	stoichiometry	quantity[176]	new[176]	_	_
25-13	3467-3468	.	_	_	_	_

#Text=Thus , this special issue presents a lot of various results , highlighting preventive effects of carotenoids in diverse conditions .
26-1	3469-3473	Thus	_	_	_	_
26-2	3474-3475	,	_	_	_	_
26-3	3476-3480	this	abstract[177]	giv[177]	_	_
26-4	3481-3488	special	abstract[177]	giv[177]	_	_
26-5	3489-3494	issue	abstract[177]	giv[177]	_	_
26-6	3495-3503	presents	_	_	_	_
26-7	3504-3505	a	abstract[178]	giv[178]	_	_
26-8	3506-3509	lot	abstract[178]	giv[178]	_	_
26-9	3510-3512	of	abstract[178]	giv[178]	_	_
26-10	3513-3520	various	abstract[178]	giv[178]	_	_
26-11	3521-3528	results	abstract[178]	giv[178]	_	_
26-12	3529-3530	,	_	_	_	_
26-13	3531-3543	highlighting	_	_	_	_
26-14	3544-3554	preventive	abstract|abstract[180]	new|new[180]	_	_
26-15	3555-3562	effects	abstract[180]	new[180]	_	_
26-16	3563-3565	of	abstract[180]	new[180]	_	_
26-17	3566-3577	carotenoids	abstract[180]|substance[181]	new[180]|giv[181]	coref	27-7[184_181]
26-18	3578-3580	in	abstract[180]|substance[181]	new[180]|giv[181]	_	_
26-19	3581-3588	diverse	abstract[180]|substance[181]|abstract[182]	new[180]|giv[181]|new[182]	_	_
26-20	3589-3599	conditions	abstract[180]|substance[181]|abstract[182]	new[180]|giv[181]|new[182]	_	_
26-21	3600-3601	.	_	_	_	_

#Text=In addition , some properties of single carotenoids are presented to deepen the knowledge on this fascinating group of compounds .
27-1	3602-3604	In	_	_	_	_
27-2	3605-3613	addition	_	_	_	_
27-3	3614-3615	,	_	_	_	_
27-4	3616-3620	some	abstract[183]	new[183]	_	_
27-5	3621-3631	properties	abstract[183]	new[183]	_	_
27-6	3632-3634	of	abstract[183]	new[183]	_	_
27-7	3635-3641	single	abstract[183]|substance[184]	new[183]|giv[184]	_	_
27-8	3642-3653	carotenoids	abstract[183]|substance[184]	new[183]|giv[184]	_	_
27-9	3654-3657	are	_	_	_	_
27-10	3658-3667	presented	_	_	_	_
27-11	3668-3670	to	_	_	_	_
27-12	3671-3677	deepen	_	_	_	_
27-13	3678-3681	the	abstract[185]	new[185]	_	_
27-14	3682-3691	knowledge	abstract[185]	new[185]	_	_
27-15	3692-3694	on	abstract[185]	new[185]	_	_
27-16	3695-3699	this	abstract[185]|abstract[186]	new[185]|new[186]	_	_
27-17	3700-3711	fascinating	abstract[185]|abstract[186]	new[185]|new[186]	_	_
27-18	3712-3717	group	abstract[185]|abstract[186]	new[185]|new[186]	_	_
27-19	3718-3720	of	abstract[185]|abstract[186]	new[185]|new[186]	_	_
27-20	3721-3730	compounds	abstract[185]|abstract[186]|place	new[185]|new[186]|new	_	_
27-21	3731-3732	.	_	_	_	_
